Injection packages
$179 / 4 weeks or $349 / 12 weeks
Nasal offer
$199 / one-month bottle
Billing
One-time purchases advertised

An order-based model for NAD+

GobyMeds lists NAD+ injections and NAD+ nasal spray within its longevity offering. Its public product pages describe an online medical review, a prescription when appropriate and delivery. The commercial distinction is that the checked offers are presented as one-time purchases, without automatic renewal or a separate membership fee.

That structure differs from a recurring monthly subscription. It does not remove the need for follow-up, future prescriptions or a second payment if treatment continues. This profile examines the documented purchasing model; it does not report a completed consultation, an order we received or an independent assessment of the clinicians and pharmacies involved.

Read the injection package by its full price

The injection page lists $179 for the shorter package and $349 for the longer package. Although the headings use one-month and three-month language, the supply descriptions specify four and twelve weeks. A reader budgeting by calendar month should preserve that distinction rather than silently treating a four-week interval as thirty or thirty-one days.

The longer option advertises a rounded $116 monthly equivalent. Dividing $349 by three produces approximately $116.33, while the amount actually committed is $349. A lower equivalent is not the price of a small first payment. Verify the selected supply, prescription and charge together before comparing this offer with another provider's billing schedule.

The nasal offer is a separate product

GobyMeds lists the nasal spray at $199 for a one-month bottle. The public specification gives a 15 mL bottle and a concentration of 300 mg/mL. Those details identify the advertised preparation more clearly than a price alone, but they do not establish equivalence to an injectable vial or an IV appointment.

The nasal page also describes a one-time purchase. Its bottle size should not be used to calculate an interchangeable injection regimen or to infer how much reaches a particular tissue. We keep the nasal review separate so that route, supply information and unresolved pharmacy questions remain visible instead of disappearing into a single brand recommendation.

Included services and remaining questions

The checked pages describe online visits, follow-up support and shipping within the offer. Injection supplies are also listed for the injectable package. These inclusions are provider statements, not results of our own service test. Ask which contact handles clinical questions, what support is available after delivery and whether any required testing creates an additional charge.

GobyMeds describes a refund when the medical review finds someone ineligible. That condition should not be expanded into a general right to return dispensed medication or obtain a refund after changing one's mind. Before ordering, obtain the applicable terms for screening, pharmacy fulfillment, damaged deliveries and any later request for another supply.

Evidence and eligibility still matter

The product pages identify the NAD+ preparations as compounded and not FDA-approved. They also describe prescription and location restrictions. A visible online price therefore does not guarantee that the same preparation is available or clinically appropriate for every reader, and the absence of recurring billing says nothing about the evidence for treatment.

Energy and healthy-aging statements on a sales page require route-specific clinical support. We have not verified those outcomes for GobyMeds' finished preparations. This provider is useful in the register because its purchase periods and several inclusions are documented. A decision still needs an individualized clinical discussion and confirmation of the exact product being dispensed.

Useful distinctions

  • Full injection package prices published
  • Separate nasal bottle specification
  • No automatic renewal advertised

Limitations to weigh

  • Four-week periods differ from calendar months
  • Eligibility and state availability apply
  • Clinical outcomes not independently verified

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. GobyMeds: NAD+ injection packages Provider
  2. GobyMeds: NAD+ nasal spray Provider
  3. GobyMeds: longevity treatment overview Provider
  4. FDA: Compounding questions and answers Regulator